Telomir Pharmaceuticals (TELO) Assets (2022 - 2026)
Telomir Pharmaceuticals (TELO) posted Assets of $7.3 million for Q4 2025, down 0.82% sequentially from $7.4 million in Q3 2025, and up 454.48% YoY from $1.3 million in Q4 2024.
Telomir Pharmaceuticals (TELO) Assets (2022 - 2026) Analysis & Trends
Telomir Pharmaceuticals has reported Assets for 4 years, with the latest figure at $7.3 million in Q4 2025.
- Quarterly Assets rose 454.48% year-over-year to $7.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.3 million (up 454.48% YoY) and the FY2025 annual result came in at $7.3 million, up 454.48% from the prior year.
- Assets fell to $7.3 million in Q4 2025 per TELO's latest filing, from $7.4 million in the prior quarter.
- Over five years, Assets peaked at $7.4 million in Q3 2025 and troughed at $48730.0 in Q4 2022.
- A 4-year average of $2.9 million and a median of $1.7 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2025: Assets soared 9696.36% in 2023, then sank 85.98% in 2025.
- Over 4 years, Assets stood at $48730.0 in 2022, then jumped by 9696.36% to $4.8 million in 2023, then sank by 72.26% to $1.3 million in 2024, then jumped by 454.48% to $7.3 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $7.3 million, $7.4 million, and $829611.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Telomir Pharmaceuticals | 69.05 Mn | 69.05 Mn | - | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.37 Mn |
| Dec 31, 2025 | 7.34 Mn |
| Sep 30, 2025 | 7.40 Mn |
| Jun 30, 2025 | 829,611.00 |
| Mar 31, 2025 | 491,188.00 |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 2.10 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 4.77 Mn |
| Dec 31, 2022 | 48,730.00 |